comparemela.com

Page 20 - Gary Jacobs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

OKYO Pharma Limited s lead asset receives US patent protection covering its use in dry eye disease

OK-101 is expected to go straight into phase II clinical trials in the fourth quarter of next year

OKYO Pharma Ltd is looking to take its dry eye disease treatment straight into phase II clinical trials

If all goes to plan, the study should begin in the fourth quarter of next year

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.